Cite
HARVARD Citation
Saint-Ghislain, M. et al. (2022). MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients. European journal of cancer. pp. 105-112. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Saint-Ghislain, M. et al. (2022). MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients. European journal of cancer. pp. 105-112. [Online].